Skip to content

Feed Screener MCP Methodology

⌘K

EN

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
AMF · FR
BAFIN · DE

Product

Ask the record
Help
Methodology
Signal backtests
Terms
Privacy notice
Object to processing

Language

English Español Français

Feed Screener MCP Methodology

English Español Français

Pricing Sign in

DENG KE LI — Rich Pharmaceuticals, Inc. insider · InsiderLens

/ / DENG KE LI

DENG KE LI

Director at Rich Pharmaceuticals, Inc. · on record since Jul 23, 2012
CEO at Rich Pharmaceuticals, Inc. · on record since Jul 23, 2012

Insider trading activity of DENG KE LI

No transactions on record for DENG KE LI.

Track record of DENG KE LI

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of DENG KE LI

Co-insiders of DENG KE LI

Chang BenRich Pharmaceuticals, Inc.
CHAO JUN XIONGRich Pharmaceuticals, Inc.
Chou David Chih-KuangRich Pharmaceuticals, Inc.
SALVADOR CAROLE A.Rich Pharmaceuticals, Inc.
WEBSTER SEANRich Pharmaceuticals, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

No transactions on record. Reset filters